EPIC |
HLN |
Sector |
Pharma and Biotech |
ISIN |
GB00BMX86B70 |
Market Sector |
MAIN |
Market Segment |
SET1 |
Main Indices |
FTSE 100, FTSE 350, FTSE All-Share |
Country of register |
Great Britain |
Currency |
British Pound |
Market Cap |
£34,636m |
NMS |
7,500 |
Shares in issue |
9,032m |
Date Listed |
n/a |
|
Final |
Interim |
Ex-Div |
24-Apr-25 |
15-Aug-24 |
Paid |
05-Jun-25 |
19-Sep-24 |
Amount |
4.60p |
2.00p |
16:58 |
20,000 @ 397.01p |
16:35 |
1,097 @ 383.50p |
16:35 |
412,451 @ 383.50p |
16:35 |
8,425 @ 383.50p |
16:35 |
14,060 @ 383.50p |
CEO |
Brian McNamara |
CFO |
Dawn Allen |
Top of Page
You are here:
research